NEW YORK (GenomeWeb) – Grifols today announced the Procleix HEV assay for detection of hepatitis E has received CE marking.

Developed in collaboration with Hologic, the test uses nucleic acid amplification technology for the fully automated detection of hepatitis E virus RNA in blood, tissue, and organ donors. The Procleix HEV assay detects all four genotypes of the virus in plasma and serum specimens and will be sold for use on the Procleix Panther system in parts of Europe and other geographies that recognize CE marking.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.